Dengue NS1Ag +IgG/IgM Combo
- UID
- MFG/IVD/2021/000055_f5196b09d2b17fc72e2b3f4bdf086efa_39137e31b4817f0ebf918b349defa142
- Device class
- Class C
- Brand name
- RAPHA SERO
- License holder
- M/s Rapha Diagnostics PVt. Ltd.,
- Approving authority
- Central Drug Standard Control Organisation, South Zone
- Product information
- N'SURE Dengue NS1Ag +IgG/IgM Combo is a rapid, qualitative immunochromatographic assay for the detection of dengue virus NS1 antigen and antibodies to Dengue virus (RAPHA SERO) in human serum or plasma. The N'SURE Dengue NS1Ag+IgG/IgM Combo Rapid Test is only intended for initial screening and reactive samples should be confirmed by a supplemental assay such as IgG/IgM ELISA, RT-PCR or HI (RAPHA SERO) test. This is an In vitro diagnostic test for professional use only
Dengue NS1Ag +IgG/IgM Combo is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID MFG/IVD/2021/000055_f5196b09d2b17fc72e2b3f4bdf086efa_39137e31b4817f0ebf918b349defa142. This device is marketed under the brand name RAPHA SERO. The license holder is M/s Rapha Diagnostics PVt. Ltd.,, and it is classified as Device Class Class C. The approving authority is Central Drug Standard Control Organisation, South Zone.
This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.